- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/22 - Hormones
Patent holdings for IPC class A61K 38/22
Total number of patents in this class: 2676
10-year publication summary
222
|
209
|
194
|
198
|
161
|
169
|
156
|
132
|
144
|
107
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Mondobiotech Laboratories AG | 311 |
82 |
Novo Nordisk A/S | 2286 |
47 |
Mayo Foundation for Medical Education and Research | 3230 |
37 |
Eli Lilly and Company | 3861 |
34 |
Hanmi Pharm. Co., Ltd. | 573 |
33 |
MannKind Corporation | 518 |
31 |
BioMarin Pharmaceutical Inc. | 374 |
28 |
Rani Therapeutics, LLC | 200 |
28 |
Ascendis Pharma Growth Disorders A/S | 56 |
27 |
Zealand Pharma A/S | 259 |
27 |
The Board of Trustees of the Leland Stanford Junior University | 6441 |
26 |
The Regents of the University of California | 20015 |
25 |
Adocia | 144 |
25 |
Transdermal Biotechnology, Inc. | 76 |
24 |
Janssen Pharmaceutica N.V. | 3376 |
22 |
Sanofi | 4081 |
21 |
University of Florida Research Foundation, Inc. | 4035 |
18 |
University of Miyazaki | 135 |
18 |
Duke University | 3078 |
17 |
Igisu Co., Ltd | 22 |
17 |
Other owners | 2089 |